In ALS, mutated OPTN seems to have neurodegenerative effects via loss-of-function possibly leading to dysregulated NF-κB activity, although it is still unclear whether this happens directly in neurons or through non-cell autonomous mechanisms. This evidence concerns the gene NFKB1 and amyotrophic lateral sclerosis.